Manejo terapéutico de la crisis asmática en la atención primaria de salud

Abstract

Introduction: We call asthmatic crisis, to the progressive state where it is difficult to breathe, which is accompanied by dyspnea, cough or chest pain, it is important to identify in a timely manner for immediate treatment and afterwards to identify the severity of this pathology. In contrast asthma in a respiratory tract disorder that arise from the type of chronic inflammation of the bronchial epithelium against environmental etiological agents that includes genetics, inheritance, humidity, low temperatures, toxic irritant agents and various social factors. Objective; General: Identify the current treatment of the asthmatic crisis, through the systematic review of scientific articles, at the primary health care level. Specific: To know the therapeutic dose of the treatment in patients from 12 years of age, for asthmatic crisis, and, to identify the collateral effects of the treatment of the asthmatic crisis. Method: The methodology applied in this project is the review of scientific articles, which are centered on the following pages of virtual libraries, which have AAA recognition, which are: Scielo, PUBMED, COCRHANE, DIALNET, and, MEDLINE, We have identified about 18 articles that meet the proposed theme, taking the most important of each of its results. Conclusion: It was concluded that in PHC, asthma attacks are treated with short-acting β2-adrenergic agonists such as salbutamol or terbutaline and the side effects are: muscle tremor, tachycardia, hypocalcemia and hypoxemia.